two new therapies for advanced breast cancer

February 1996

Zeneca will be promoting two new therapies for advanced breast cancer...Zoladex (goserelin implant) and Arimidex (anastrozole).

Zoladex is already on the market for treating prostate cancer and endometriosis.

Now it's also approved for metastatic breast cancer...in women who have NOT yet gone through menopause.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 120+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote